CD27 co-stimulation enhances activation and survival of CD8+ T cells (60, 61), prevents activation-induced cell death (60) and supports the presence of tumor-specific CD8+ T cells residing within established melanoma (63). This evidence concerns the gene CD8A and neoplasm.